156 related articles for article (PubMed ID: 34523746)
21. Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.
Abdul-Ghani RA; Loutfy N; Hassan A
Parasitol Res; 2009 Oct; 105(4):899-906. PubMed ID: 19588166
[TBL] [Abstract][Full Text] [Related]
22. Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches.
Mafud AC; Ferreira LG; Mascarenhas YP; Andricopulo AD; de Moraes J
Trends Parasitol; 2016 Nov; 32(11):874-886. PubMed ID: 27593339
[TBL] [Abstract][Full Text] [Related]
23. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents.
Kasago FM; Häberli C; Keiser J; Masamba W
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446846
[TBL] [Abstract][Full Text] [Related]
25. Antischistosomal activity of artemisinin derivatives in vivo and in patients.
Saeed MEM; Krishna S; Greten HJ; Kremsner PG; Efferth T
Pharmacol Res; 2016 Aug; 110():216-226. PubMed ID: 26902577
[TBL] [Abstract][Full Text] [Related]
26. Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro.
Botros SS; William S; Beadle JR; Valiaeva N; Hostetler KY
Antimicrob Agents Chemother; 2009 Dec; 53(12):5284-7. PubMed ID: 19704122
[TBL] [Abstract][Full Text] [Related]
27. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
Wang Y; Xu J; Xia C
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
[TBL] [Abstract][Full Text] [Related]
28. Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids.
Wu J; Wang X; Chiu FCK; Häberli C; Shackleford DM; Ryan E; Kamaraj S; Bulbule VJ; Wallick AI; Dong Y; White KL; Davis PH; Charman SA; Keiser J; Vennerstrom JL
J Med Chem; 2020 Apr; 63(7):3723-3736. PubMed ID: 32134263
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapeutic nitroheterocycles. Antischistosomal properties of nitrofurylvinyl and nitrothienylvinyl heterocycles.
Henry DW; Brown VH; Croy M; Johansson JG
J Med Chem; 1973 Nov; 16(11):1287-91. PubMed ID: 4747970
[No Abstract] [Full Text] [Related]
30. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
Doenhoff MJ; Cioli D; Utzinger J
Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
[TBL] [Abstract][Full Text] [Related]
31. Natural products with antischistosomal activity.
de Moraes J
Future Med Chem; 2015; 7(6):801-20. PubMed ID: 25996071
[TBL] [Abstract][Full Text] [Related]
32. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.
Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM
Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473
[TBL] [Abstract][Full Text] [Related]
33. Will new antischistosomal drugs finally emerge?
Cioli D; Valle C; Angelucci F; Miele AE
Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
[TBL] [Abstract][Full Text] [Related]
34. Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.
Moreira-Filho JT; Silva AC; Dantas RF; Gomes BF; Souza Neto LR; Brandao-Neto J; Owens RJ; Furnham N; Neves BJ; Silva-Junior FP; Andrade CH
Front Immunol; 2021; 12():642383. PubMed ID: 34135888
[TBL] [Abstract][Full Text] [Related]
35. Antischistosomal activity of N,N'-arylurea analogs against Schistosoma japonicum.
Yao H; Liu F; Chen J; Li Y; Cui J; Qiao C
Bioorg Med Chem Lett; 2016 Mar; 26(5):1386-90. PubMed ID: 26856921
[TBL] [Abstract][Full Text] [Related]
36. The potential of artemether for the control of schistosomiasis.
Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
[TBL] [Abstract][Full Text] [Related]
37. Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978).
Wang C; Zhao Q; Vargas M; Jones JO; White KL; Shackleford DM; Chen G; Saunders J; Ng AC; Chiu FC; Dong Y; Charman SA; Keiser J; Vennerstrom JL
J Med Chem; 2016 Dec; 59(23):10705-10718. PubMed ID: 27933964
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Antischistosomal Drug Leads Based on Tetraazamacrocyclic Derivatives and Their Metal Complexes.
Khan MO; Keiser J; Amoyaw PN; Hossain MF; Vargas M; Le JG; Simpson NC; Roewe KD; Freeman TN; Hasley TR; Maples RD; Archibald SJ; Hubin TJ
Antimicrob Agents Chemother; 2016 Sep; 60(9):5331-6. PubMed ID: 27324765
[TBL] [Abstract][Full Text] [Related]
39. New 1,3-benzodioxole derivatives: Synthesis, evaluation of in vitro schistosomicidal activity and ultrastructural analysis.
Mariz Gomes da Silva LM; de Oliveira JF; Silva WL; da Silva AL; de Almeida Junior ASA; Barbosa Dos Santos VH; Alves LC; Brayner Dos Santos FA; Costa VMA; Aires AL; de Lima MDCA; Albuquerque MCPA
Chem Biol Interact; 2018 Mar; 283():20-29. PubMed ID: 29366735
[TBL] [Abstract][Full Text] [Related]
40. Antischistosomal Properties of Sclareol and Its Heck-Coupled Derivatives: Design, Synthesis, Biological Evaluation, and Untargeted Metabolomics.
Crusco A; Whiteland H; Baptista R; Forde-Thomas JE; Beckmann M; Mur LAJ; Nash RJ; Westwell AD; Hoffmann KF
ACS Infect Dis; 2019 Jul; 5(7):1188-1199. PubMed ID: 31083889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
